Daniel T. Scavilla - Jan 26, 2024 Form 4 Insider Report for GLOBUS MEDICAL INC (GMED)

Role
President, CEO, Director
Signature
/s/ Kelly G. Huller, Attorney-in-Fact
Stock symbol
GMED
Transactions as of
Jan 26, 2024
Transactions value $
$0
Form type
4
Date filed
1/30/2024, 04:37 PM
Previous filing
Oct 19, 2023
Next filing
Nov 8, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GMED Stock Option (Right to Buy Class A Common Stock) Award $0 +140K $0.00 140K Jan 26, 2024 Class A Common Stock 140K $53.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options were granted on January 26, 2024, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2025, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.